Navigation Links
Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
Date:5/14/2008

DOYLESTOWN, Pa., May 14 /PRNewswire-FirstCall/ -- The Quigley Corporation (Nasdaq: QGLY) announced positive results from a study conducted by its wholly owned subsidiary, Quigley Pharma Inc., which was conducted in chickens to evaluate the anti-viral activity of its compound QR448(a). The compound was administered to chicks that had been infected with Infectious Bronchitis Virus (IBV). The data from the study indicated that QR448(a) is efficacious against an IBV challenge in two week old specific pathogen free (SPF) chicks, confirming previous results indicating that treatment with QR448(a) before or after viral exposure has the potential to lessen or prevent disease.

Preventing and treating infectious bronchitis caused by IBV is a worldwide concern of the poultry industry which calculates its loses due to this disease in lowered weight gains and feed efficiency in broilers, lowered production and quality of eggs in layers and breeders, mortality, clean-up costs and disruption to operations.

The Company initiated its investigations into the effectiveness of this compound based on feedback from poultry industry leaders who expressed an increasing need for additional products to combat Infectious Bronchitis (IBV).

Dr Richard Rosenbloom, Executive Vice President and Chief Operating Officer of Quigley Pharma stated: "With the increased emphasis by the animal health community on prevention as well as treatment of disease, the results from our experiments in chickens have demonstrated that our QR448(a) compound can prevent as well as treat 2 week old SPF chicks from infection when challenged with IBV in a dose response experimental design. We believe this innovative, non-vaccine, broad spectrum antiviral has the potential t
'/>"/>

SOURCE The Quigley Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
2. Kosan Announces Data Presentations at ASCO 2008 Annual Meeting
3. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
4. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
5. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
6. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
7. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
8. Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
9. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
10. Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
11. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...e/ -- Reportlinker.com announces that a new market..., Global Markets for Assisted Reproductive Devi...4742/Global-Markets-for-Assisted-Reproductive-Devi...=pr&utm_campaign=prnewswire ,, Global Mar... Countries in Europe and Japan. This report includ...
(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...
(Date:11/20/2009)...swire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin ...known as DOR BioPharma, Inc., a late-stage biotech... a consortium to develop thermostable technology t...nes. Soligenix received a $9.4 million grant from ...iseases (NIAID), a division of the National Instit...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Blue Shield of California Expands CalPERS NetValue Service Area 52337 1Blue Shield of California Expands CalPERS NetValue Service Area 52337 2Blue Shield of California Expands CalPERS NetValue Service Area 52337 3Free Drug Card Has Saved Washington Residents 242 6 Million 52334 1Free Drug Card Has Saved Washington Residents 242 6 Million 52334 2Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 1Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 2Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 3Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 4Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 5Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 6Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 7Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 8
(Date:11/21/2009)... Eric J. Hall, president and chief executive off...) issued the following statement regarding the inc...f the new annual wellness for Medicare beneficiari...Care Act" that was introduced last night: , ...ber 21, 2009 -- Eric J. Hall, president and chief ...
(Date:11/20/2009)...NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharm...eting of Shareholders will be held on Monday, Dece...nsider approval of two special resolutions. The fi... the sale of all or substantially all of the asset...for in the asset purchase agreement dated November...
(Date:11/20/2009)... Senators and Congressmen in Competitive Re-elec... Care Vote , Washington, ...essmen running for re-election next year in races ... Cook, may come to regret voting for House Speaker...to a breaking Zogby International/ O’Leary R...
(Date:11/20/2009)..., Israel, November 20 Ca...p://www.CVSLMEDICAL.COM , a leading,developer of a...nnounced that,the company,s Board of Directors has..., Canada and the Far East for its proprietary next...ll angioplasty (PCTA) procedures. , Cardi...
(Date:11/20/2009)...d online November 20 in the Journal of the Nation...rs and hopes that often appear in news coverage of...for both the media and journals to help alleviate ... Steven Woloshin, M.D., M.S., of Center for Medici...alth Policy and Clinical Practice in New Hampshire...
Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...SING, Mich., Feb. 3 Cherries are not only good fo...per Fruit." According to recent,data, more than 9 ...comes,from, nearly 80 percent say they,re purchasi...f cherries consumed in the U.S. are grown here,wit...
...A BEACH, Va., Feb. 3, 2009 AMERIGROUP Corporation...y, Esq., MPH has been named Chief Compliance Offic...l Company operations comply with state and federal...ties at AMERIGROUP," said John E. Littel, AMERIGRO...
...NCISCO, Feb. 3 Nile Therapeutics, Inc., (Nasdaq: ...f Executive Officer, will present a corporate over...ference in New York. The presentation will take pl...linical-stage biopharmaceutical company that devel...
...MI, Feb. 3 Baker & McKenzie, and Bankstreet G...mit aimed at informing investors,in the healthcare...y 12th at,the Harvard Club. , Internationally ...of Miami and Palm Beach, Florida,( http://www.mors...
...will provide web foundation for the newly launched...., Feb. 3 Univita Health, a new company aimed at ...to independent aging, announced the acquisition of...eation of a virtual marketplace for individuals to...
...FANG, Shandong, China, Feb. 3 /PRNewswire-Asia-Fir...etin Board: SGTI) ("Shengtai Pharmaceutical" or,"t...or of high-quality,pharmaceutical grade glucose pr...ence. , This conference will be held from Mond...
Other Medicine News:Health News:Cherries: 'America's Super Fruit' Offers Homegrown Health Benefits 2Health News:Cherries: 'America's Super Fruit' Offers Homegrown Health Benefits 3Health News:AMERIGROUP Names Finley Chief Compliance Officer 2Health News:Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference 2Health News:James G. Schwade, M.D. to Deliver Keynote Address to Financial and Investment Industry in New York 2Health News:Univita Health Acquires Leading Web Services Company 2Health News:Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference 2Health News:Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference 3
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: